Literature DB >> 26614640

CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.

Matthew J Butcher1, Chih-I Wu1, Tayab Waseem1, Elena V Galkina2.   

Abstract

The adaptive immune response is involved in the development and progression of atherosclerosis and IL-17A(+) cells play a role in this disease. Although elevated number of CD4(+) IL-17A(+) (Th17) and IL-17A(+)TCRγδ(+) T cells are found within murine atherosclerotic aortas and human plaques, the mechanisms governing IL-17A(+) T-cell migration to atherosclerotic lesions are unclear. The chemokine receptor CXCR6 is expressed on several T-cell subsets and plays a pro-atherogenic role in atherosclerosis. Here, we used CXCR6-deficient (Cxcr6 (GFP/GFP) ) apolipoprotein E-deficient (Apoe (-/-) ) mice to investigate the involvement of CXCR6 in the recruitment IL-17A(+) T cells to atherosclerotic aortas. Flow cytometric analyses revealed reductions in Th17 and IL-17A(+)TCRγδ(+) T cells within aged Cxcr6 (GFP/GFP) Apoe (-/-) aortas, in comparison with age-matched Cxcr6 (GFP/+) Apoe (-/-) aortas. Although CXCR6-sufficient IL-17A(+) T cells efficiently migrated toward CXCL16, the migration of CXCR6-deficient IL-17A(+) T cells was abolished in transwell assays. Importantly, the recruitment of Cxcr6 (GFP/GFP) Apoe (-/-) IL-17A(+) T cells into the aortas of Apoe (-/-) recipients was markedly reduced in short-term adoptive transfer experiments. Altogether these results demonstrate an important role of CXCR6 in the regulation of pathological Th17 and IL-17A(+)TCRγδ(+) T-cell recruitment into atherosclerotic lesions. © The Japanese Society for Immunology. 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IL-17A; atherosclerosis; chemokine receptor; immune system; lymphocytes

Mesh:

Substances:

Year:  2015        PMID: 26614640      PMCID: PMC4888347          DOI: 10.1093/intimm/dxv068

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  37 in total

1.  Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.

Authors:  Fumitake Usui; Hiroaki Kimura; Taichi Ohshiro; Kazuki Tatsumi; Akira Kawashima; Akiyo Nishiyama; Yo-Ichiro Iwakura; Shun Ishibashi; Masafumi Takahashi
Journal:  Biochem Biophys Res Commun       Date:  2012-02-28       Impact factor: 3.575

2.  Data transformation practices in biomedical sciences.

Authors:  Mihai Valcu; Cristina-Maria Valcu
Journal:  Nat Methods       Date:  2011-02       Impact factor: 28.547

3.  Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.

Authors:  Ara M Aslanian; Israel F Charo
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

4.  Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.

Authors:  T van Es; G H M van Puijvelde; O H Ramos; F M E Segers; L A Joosten; W B van den Berg; I M Michon; P de Vos; Th J C van Berkel; J Kuiper
Journal:  Biochem Biophys Res Commun       Date:  2009-08-04       Impact factor: 3.575

5.  Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.

Authors:  Anton Gisterå; Anna-Karin L Robertson; John Andersson; Daniel F J Ketelhuth; Olga Ovchinnikova; Stefan K Nilsson; Anna M Lundberg; Ming O Li; Richard A Flavell; Göran K Hansson
Journal:  Sci Transl Med       Date:  2013-07-31       Impact factor: 17.956

6.  The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse.

Authors:  D Unutmaz; W Xiang; M J Sunshine; J Campbell; E Butcher; D R Littman
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 7.  Chemokines in atherosclerosis: proceedings resumed.

Authors:  Alma Zernecke; Christian Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-16       Impact factor: 8.311

8.  Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells.

Authors:  Hyung W Lim; Jeeho Lee; Peter Hillsamer; Chang H Kim
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 9.  Immune and inflammatory mechanisms of atherosclerosis (*).

Authors:  Elena Galkina; Klaus Ley
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.

Authors:  Elena Galkina; Alexandra Kadl; John Sanders; Danielle Varughese; Ian J Sarembock; Klaus Ley
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

View more
  15 in total

1.  miR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A.

Authors:  Yin Ren; Ruanzhong Bao; Zhujun Guo; Jin Kai; Chen-Ge Cai; Zhu Li
Journal:  Exp Ther Med       Date:  2020-11-23       Impact factor: 2.447

Review 2.  Vaccination against atherosclerosis.

Authors:  Kouji Kobiyama; Ryosuke Saigusa; Klaus Ley
Journal:  Curr Opin Immunol       Date:  2019-03-29       Impact factor: 7.486

Review 3.  Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.

Authors:  Alma Zernecke; Holger Winkels; Clément Cochain; Jesse W Williams; Dennis Wolf; Oliver Soehnlein; Clint S Robbins; Claudia Monaco; Inhye Park; Coleen A McNamara; Christoph J Binder; Myron I Cybulsky; Corey A Scipione; Catherine C Hedrick; Elena V Galkina; Tin Kyaw; Yanal Ghosheh; Huy Q Dinh; Klaus Ley
Journal:  Circ Res       Date:  2020-07-16       Impact factor: 17.367

4.  Interleukin-8 Receptor 2 (IL-8R2)-Deficient Mice Are More Resistant to Pulmonary Coccidioidomycosis than Control Mice.

Authors:  Aaron F Carlin; Suganya Viriyakosol; Sharon Okamoto; Lorraine Walls; Joshua Fierer
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

5.  Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells.

Authors:  Amara Seng; Kelsey L Krausz; Dong Pei; Devin C Koestler; Ryan T Fischer; Thomas M Yankee; Mary A Markiewicz
Journal:  Blood Adv       Date:  2020-04-14

Review 6.  How the immune system shapes atherosclerosis: roles of innate and adaptive immunity.

Authors:  Payel Roy; Marco Orecchioni; Klaus Ley
Journal:  Nat Rev Immunol       Date:  2021-08-13       Impact factor: 108.555

7.  Activation of CXCL16/CXCR6 axis aggravates cardiac ischemia/reperfusion injury by recruiting the IL-17a-producing CD1d+ T cells.

Authors:  Shijun Wang; Leilei Ma; Ji'e Yang; Zhen Dong; Jian Wu; Xiancheng Lu; Jiahong Wang; Fangjie Dai; Guowei Tu; Lei Xu; Gang Zhao; Feng Zhang; Yunzeng Zou; Junbo Ge
Journal:  Clin Transl Med       Date:  2021-02

Review 8.  Immune Mechanisms of Plaque Instability.

Authors:  Teresa Gerhardt; Arash Haghikia; Philip Stapmanns; David Manuel Leistner
Journal:  Front Cardiovasc Med       Date:  2022-01-11

Review 9.  T cell subsets and functions in atherosclerosis.

Authors:  Ryosuke Saigusa; Holger Winkels; Klaus Ley
Journal:  Nat Rev Cardiol       Date:  2020-03-16       Impact factor: 49.421

10.  Plasma chemokine CXC motif-ligand 16 as a predictor of renal prognosis in immunoglobulin A nephropathy.

Authors:  Ran Luo; Yi Yang; Yi-Chun Cheng; Dan Chang; Ting-Ting Liu; Yue-Qiang Li; Wei Dai; Mei-Ying Zuo; Yu-Lin Xu; Chun-Xiu Zhang; Shu-Wang Ge; Gang Xu
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.